Stock Split Watch: Could This Unstoppable Growth Stock Be Next?

分组1 - Eli Lilly has experienced a significant recovery, with its stock price increasing by 32% year to date, now exceeding $1,000, which may lead to speculation about a potential stock split [1][7] - The company has a strong outlook for the coming years, driven by substantial revenue growth, particularly from its obesity and type 2 diabetes treatment, tirzepatide, which contributed to a 54% year-over-year revenue increase to $17.6 billion in the third quarter [8] - Eli Lilly has a history of stock splits, with the last one occurring in 1997, and the current stock price may prompt the company to consider another split to attract more investors [5][6] 分组2 - Companies typically conduct stock splits to keep share prices within a more attractive range for investors, enhancing liquidity and making shares more accessible [2][3] - High share prices can deter potential buyers, while lower-priced stocks tend to have quicker buy and sell transactions, which is a preference for many investors [3] - Some companies, like Berkshire Hathaway, may not prioritize stock splits as their high share prices attract specific types of investors, indicating a strategic choice rather than a necessity [4]